MEDICAMEQ
Medicamen Biotech Limited (MEDICAMEQ) Stock Analysis
Medicamen Biotech Limited is an Indian pharmaceutical company manufacturing formulations and APIs with focus on CNS, anti-infectives, and niche products. It markets domestically and exports select lines. R&D and compliance underpin regulated markets access. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - Specialty & Generic
₹300.90
-5.57% 1W | +1.10% 52W
Market Cap
408 CR
P/E Ratio
40.6
52W High
₹447.6
52W Low
₹212.4
Div. Yield
0.33%
Beta
0.7
50 DMA
₹276.8
200 DMA
₹282.2
Profit Margin
4.7%
Inst. Own.
0%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 41.94 | 43.54 | 46.50 | 47.32 | 43.05 | 44.74 | 45.14 | 29.61 | 43.04 | 47.17 | 46.91 | 60.65 | 47.90 |
| Expenses | 34.99 | 38.89 | 41.60 | 41.57 | 39.60 | 39.43 | 38.43 | 31.22 | 38.43 | 42.01 | 42.53 | 55.22 | 43.57 |
| Operating Profit | 6.95 | 4.65 | 4.90 | 5.75 | 3.45 | 5.31 | 6.71 | -1.61 | 4.61 | 5.16 | 4.38 | 5.43 | 4.33 |
| OPM % | 16.57% | 10.68% | 10.54% | 12.15% | 8.01% | 11.87% | 14.86% | -5.44% | 10.71% | 10.94% | 9.34% | 8.95% | 9.04% |
| Other Income | 0.38 | 0.55 | 0.83 | 0.57 | 0.59 | 0.29 | 0.14 | 5.23 | 0.47 | 0.37 | 0.53 | 1.74 | 0.86 |
| Interest | 0.96 | 0.91 | 0.65 | 1.89 | 0.71 | 1.04 | 0.76 | 0.65 | 1.15 | 0.99 | 0.97 | 0.38 | 0.83 |
| Depreciation | 1.69 | 1.82 | 1.80 | 1.77 | 1.77 | 2.61 | 2.21 | 0.48 | 1.80 | 1.86 | 1.83 | 1.73 | 1.79 |
| Profit before tax | 4.68 | 2.47 | 3.28 | 2.66 | 1.56 | 1.95 | 3.88 | 2.49 | 2.13 | 2.68 | 2.11 | 5.06 | 2.57 |
| Tax % | 15.81% | 39.68% | 38.11% | 22.93% | 48.72% | 53.85% | 24.74% | 25.30% | 24.88% | 21.27% | 22.27% | 12.06% | 28.40% |
| Net Profit | 3.95 | 1.47 | 2.03 | 2.04 | 0.80 | 0.91 | 2.92 | 1.87 | 1.60 | 2.12 | 1.64 | 4.45 | 1.85 |
| EPS in Rs | 3.30 | 1.19 | 1.90 | 1.68 | 1.06 | 1.15 | 2.73 | 1.90 | 1.59 | 1.97 | 1.61 | 2.85 | 1.56 |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 123 | 125 | 113 | 115 | 141 | 179 | 163 | 198 | 203 |
| Expenses | 105 | 106 | 93 | 91 | 117 | 156 | 148 | 177 | 183 |
| Operating Profit | 17 | 20 | 20 | 24 | 24 | 24 | 14 | 21 | 19 |
| OPM % | 14% | 16% | 17% | 21% | 17% | 13% | 9% | 10% | 10% |
| Other Income | 4 | 2 | 1 | 2 | 2 | 2 | 6 | 3 | 4 |
| Interest | 1 | 1 | 2 | 2 | 3 | 6 | 4 | 5 | 3 |
| Depreciation | 2 | 2 | 3 | 6 | 6 | 7 | 7 | 7 | 7 |
| Profit before tax | 18 | 18 | 16 | 18 | 17 | 13 | 10 | 12 | 12 |
| Tax % | 31% | 26% | 26% | 18% | 14% | 27% | 34% | 18% | |
| Net Profit | 12 | 13 | 12 | 15 | 15 | 9 | 7 | 10 | 10 |
| EPS in Rs | 10.28 | 10.88 | 9.93 | 12.20 | 11.73 | 8.60 | 5.59 | 7.11 | 7.99 |
| Dividend Payout % | 10% | 5% | 10% | 8% | 9% | 12% | 18% | 14% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 12.0% | 12.0% | – |
| Profit CAGR | -13.0% | -4.0% | – |
Shareholding Pattern
Promoters40.46%
DIIs0.64%
Public58.83%
Promoters40.46%
FIIs0.05%
DIIs0.59%
Public58.84%
Promoters40.46%
FIIs0.02%
DIIs0.44%
Public59.02%
Promoters40.46%
FIIs0.10%
Public59.39%
Promoters40.46%
FIIs0.07%
DIIs0.40%
Public59.01%
Promoters43.21%
FIIs0.19%
DIIs0.20%
Public56.40%
Promoters43.21%
FIIs0.12%
DIIs0.99%
Public55.69%
Promoters43.16%
FIIs0.12%
DIIs0.69%
Public55.99%
Promoters40.46%
FIIs0.10%
Public59.39%
Promoters40.46%
FIIs0.07%
DIIs0.40%
Public59.01%
MEDICAMEQ
Holdings Analysis
Key strengths & risk signals
54
Overall
42
Fundamental
67
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
BEARISH TREND! 50-day average (276.8) is below 200-day average (282.2) - negative signal.
POSITIVE YEAR! Stock gained 1.1% in the last year.
LOWER HALF! Trading at 37.6% of 52W range - weakness visible.
Strengths (4)
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
BULLISH SENTIMENT! In last 30 days: 16 up days, 14 down days. Avg volume on up days: 108,002 vs down days: 50,067. Ratio: 2.16x
LOW VOLATILITY! Beta of 0.70 - stable stock, less market risk.
STRONG POSITION! Current price (300.9) is above both moving averages.
Fundamental & Technical Analysis
54Overall
42Fundamental
67Technical
Fundamental Breakdown
Growth Quality
13/30
Revenue CAGR: 12.0% (GOOD, 11/15). Profit CAGR: -13.4% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! 4.7% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.33% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
5/20
TOO MUCH PUBLIC HOLDING! 56.44% public ownership - higher volatility risk.
Stability Index
8/10
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (276.8) is below 200-day average (282.2) - negative signal.
Price Position
8/10
STRONG POSITION! Current price (300.9) is above both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
4/10
POSITIVE YEAR! Stock gained 1.1% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 16 up days, 14 down days. Avg volume on up days: 108,002 vs down days: 50,067. Ratio: 2.16x
RSI
3/5
NEUTRAL! RSI at 49.1 - balanced momentum.
52W Range
2/5
LOWER HALF! Trading at 37.6% of 52W range - weakness visible.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - -5.6% (1 week), -3.9% (1 month), 22.6% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.70 - stable stock, less market risk.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDICAMEQ | ₹300.90 | 40.6 | 4.7% | 12.0% | -13.4% | +1.1% | 54 | BREAKDOWN | -4.5% | -46.2% | +11.4% | -21.0% |
| ALBERTDAVD | ₹791.60 | 20 | 6.2% | -1.1% | – | +1.3% | 51 | BREAKDOWN | +305.1% | -249.5% | +43.5% | +17.9% |
| AAREYDRUGS | ₹104.10 | 70.8 | 0.9% | 4.5% | 1.7% | +32.7% | 58 | APPROACHING RESISTANCE | -28.6% | -37.5% | -56.4% | -76.5% |
| AMBALALSA | ₹40.60 | 23.9 | 6.6% | 5.8% | 15.9% | +21.3% | 64 | BREAKDOWN | -51.2% | -38.5% | -7.2% | -33.4% |
| BROOKS | ₹70.10 | 15.6 | 15.9% | 11.0% | – | -52.9% | 62 | BREAKOUT | -118.8% | -220.0% | -9.8% | +13.9% |
| NECLIFE | ₹10.10 | 28.9 | – | – | – | -24.9% | 46 | BREAKDOWN | -75.6% | -77.3% | – | – |
| MEDICO | ₹22.80 | 13.7 | 5.8% | 13.8% | 21.9% | -55.7% | 55 | BREAKDOWN | +38.9% | -57.6% | +81.2% | +22.2% |
| NATCAPSUQ | ₹160.00 | – | -8.1% | 3.6% | – | -32.4% | 46 | BREAKDOWN | +1.8% | +14.0% | +7.7% | -16.8% |
Data from TradeAlone · Updated daily
No news tagged for MEDICAMEQ yet.
